98%
921
2 minutes
20
While abnormalities related to carbohydrates (glycans) are frequent for patients with rare and undiagnosed diseases as well as in many common diseases, these glycan-related phenotypes (glycophenotypes) are not well represented in knowledge bases (KBs). If glycan-related diseases were more robustly represented and curated with glycophenotypes, these could be used for molecular phenotyping to help to realize the goals of precision medicine. Diagnosis of rare diseases by computational cross-species comparison of genotype-phenotype data has been facilitated by leveraging ontological representations of clinical phenotypes, using Human Phenotype Ontology (HPO), and model organism ontologies such as Mammalian Phenotype Ontology (MP) in the context of the Monarch Initiative. In this article, we discuss the importance and complexity of glycobiology and review the structure of glycan-related content from existing KBs and biological ontologies. We show how semantically structuring knowledge about the annotation of glycophenotypes could enhance disease diagnosis, and propose a solution to integrate glycophenotypes and related diseases into the Unified Phenotype Ontology (uPheno), HPO, Monarch and other KBs. We encourage the community to practice good identifier hygiene for glycans in support of semantic analysis, and clinicians to add glycomics to their diagnostic analyses of rare diseases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859258 | PMC |
http://dx.doi.org/10.1093/database/baz114 | DOI Listing |
Mamm Genome
September 2025
Department of Animal Health and Anatomy, Center for Animal Biotechnology and Gene Therapy, Universitat Autònoma de Barcelona, Travessera Dels Turons, 08193, Cerdanyola del Vallès, Barcelona, Spain.
The mouse remains the principal animal model for investigating human diseases due, among other reasons, to its anatomical similarities to humans. Despite its widespread use, the assumption that mouse anatomy is a fully established field with standardized and universally accepted terminology is misleading. Many phenotypic anatomical annotations do not refer to the authority or origin of the terminology used, while others inappropriately adopt outdated or human-centric nomenclature.
View Article and Find Full Text PDFIEEE Trans Comput Biol Bioinform
September 2025
Accurately identifying associations between human genes (proteins) and clinical phenotypes is critical for advancing drug development and precision medicine. While the human phenotype ontology (HPO) standardizes clinical phenotypes, current computational approaches for predicting human protein-phenotype associations suffer from two limitations: (1) underutilization of multimodal protein-related information and (2) lack of state-of-the-art deep learning representations tailored to diverse data modalities, such as text and sequence. To overcome these limitations, we introduce MultiFusion2HPO, a novel multimodal model that integrates diverse features and advanced learning methods from multiple data sources to enhance the prediction of human protein-HPO associations.
View Article and Find Full Text PDFJTCVS Open
August 2025
Division of Congenital Heart Surgery, Department of Surgery, Texas Children's Hospital Heart Center and Baylor College of Medicine, Houston, Tex.
Objective: Pediatric pulmonary vein stenosis (PVS) is associated with substantial morbidity and mortality for the subset of patients with recurrent or progressive disease. The molecular mechanisms underlying the development and trajectory of PVS remain unclear. This study characterizes the transcriptome of clinical and phenotypic subtypes of PVS.
View Article and Find Full Text PDFFront Pediatr
August 2025
Laboratorio Clínico Especializado, Clínica Universitaria Colombia, Clínica Colsanitas, Bogotá, Colombia.
Introduction: The integration of genetic testing in pediatrics has advanced significantly in recent years. The incorporation of technologies such as Next Generation Sequencing (NGS) and array-based Comparative Genomic Hybridization (aCGH) in increasingly younger patients has accelerated the transition toward precision medicine.
Methods: This retrospective cross-sectional study (January 2021-June 2024) included 187 neonates (≤90 days old) from the NICUs of the Clínica Colsanitas network in Bogotá, Colombia and evaluate the diagnostic yield for genomic testing comprising 82 Whole Exome Sequencing (WES) and 125 aCGH tests, with 18 patients undergoing both.
JBMR Plus
October 2025
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Genome-wide association studies (GWAS) relevant to osteoporosis have identified hundreds of loci; however, understanding how these variants influence the phenotype is complicated because most reside in non-coding DNA sequence that serves as transcriptional enhancers and repressors. To advance knowledge on these regulatory elements in osteoclasts (OCs), we performed Micro-C analysis, which informs on the genome topology of these cells and integrated the results with transcriptome and GWAS data to further define loci linked to BMD. Using blood cells isolated from 4 healthy participants aged 31-61 yr, we cultured OC in vitro and generated a Micro-C chromatin conformation capture dataset.
View Article and Find Full Text PDF